237 related articles for article (PubMed ID: 32795376)
1. Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke.
Zhao H; Li F; Huang Y; Zhang S; Li L; Yang Z; Wang R; Tao Z; Han Z; Fan J; Zheng Y; Ma Q; Luo Y
J Neuroinflammation; 2020 Aug; 17(1):237. PubMed ID: 32795376
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
[TBL] [Abstract][Full Text] [Related]
3. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
4. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
[TBL] [Abstract][Full Text] [Related]
5. Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Manske MK; Witzig TE; Novak AJ; Ansell SM
Blood; 2011 Sep; 118(10):2809-20. PubMed ID: 21719603
[TBL] [Abstract][Full Text] [Related]
6. Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients
Long D; Yu S; Zhang L; Guo Y; Xu S; Rao Y; Huang Z; Luo Q; Li J
Front Immunol; 2022; 13():938556. PubMed ID: 36203602
[TBL] [Abstract][Full Text] [Related]
7. Serum Interleukin-33 is a Novel Predictive Biomarker of Hemorrhage Transformation and Outcome in Acute Ischemic Stroke.
Chen Z; Hu Q; Huo Y; Zhang R; Fu Q; Qin X
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105506. PubMed ID: 33307292
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
[TBL] [Abstract][Full Text] [Related]
9. sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study.
Trancă S; Oever JT; Ciuce C; Netea M; Slavcovici A; Petrișor C; Hagău N
Eur J Trauma Emerg Surg; 2017 Jun; 43(3):363-370. PubMed ID: 27169526
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases.
Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N
J Clin Exp Hematop; 2013; 53(3):197-205. PubMed ID: 24369221
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis.
Makis AC; Galanakis E; Hatzimichael EC; Papadopoulou ZL; Siamopoulou A; Bourantas KL
J Infect; 2005 Oct; 51(3):206-10. PubMed ID: 16230217
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells.
Tsai MH; Chiou SH; Chow KC
Int J Oncol; 2001 Nov; 19(5):1049-55. PubMed ID: 11605008
[TBL] [Abstract][Full Text] [Related]
15. Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
Sonbol MB; Maurer MJ; Stenson MJ; Allmer C; LaPlant BR; Weiner GJ; Macon WR; Cerhan JR; Witzig TE; Gupta M
Am J Hematol; 2014 Dec; 89(12):E223-7. PubMed ID: 25164110
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors.
Yoshida S; Morii K
J Surg Oncol; 2000 Oct; 75(2):131-5. PubMed ID: 11064393
[TBL] [Abstract][Full Text] [Related]
17. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke.
Yu S; Luo Y; Zhang T; Huang C; Fu Y; Zhang Q; Zeng F; Huang H; Zhang C; Guo Z
BMC Neurosci; 2021 Feb; 22(1):8. PubMed ID: 33546596
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor-associated macrophages on serum soluble IL-2R levels in B-cell lymphomas.
Sakai A; Yoshida N
J Clin Exp Hematop; 2014; 54(1):49-57. PubMed ID: 24942946
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
